Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists

US Patent 11254655 · Granted Feb 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Imidazolo indazole compounds as JAK inhibitors2025
Pyrimidine compound as JAK kinase inhibitor2024
Fused pyrimidine pyridinone compounds as JAK inhibitors2023
Pyrimidine compound as JAK kinase inhibitor2022
Imidazole and triazole containing bicyclic compounds as JAK inhibitors2022
Fused imidazo-piperidine JAK inhibitor compound2021
Pyrimidine compound as JAK kinase inhibitor2021
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors2021
Imidazole and triazole containing bicyclic compounds as JAK inhibitors2020
Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists2020
Pyrimidine compound as JAK kinase inhibitor2020
Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors2020